A variety of pulmonary disorders, including cystic fibrosis, are potentially amenable to treatment in which a therapeutic gene is directly transferred to the bronchial epithelium. This is difficult to accomplish because the majority of airway epithelial cells replicate slowly and/or are terminally differentiated. Adenovirus vectors may circumvent this problem, since they do not require target cell proliferation to express exogenous genes. To evaluate the diversity of airway epithelial cell targets for in vivo adenovirus-directed gene transfer, a replication deficient recombinant adenovirus containing the Escherichia coli lacZ ((3-ga-lactosidase [(3-gall) Invest. 1993. 91:225-234.)
Introduction
Cystic fibrosis (CF)', one ofthe most common lethal hereditary disorders of Caucasians, has its major manifestations in the lung, with respiratory failure responsible for 95% of deaths of affected individuals (1, 2) . In the context that CF is an autosomal recessive disorder involving a single gene (3) (4) (5) , the respiratory manifestations of CF are potentially amenable to treatment by somatic gene therapy, where the normal human cystic fibrosis transmembrane conductance regulator (CFTR) cDNA and appropriate controlling elements are transferred directly to the airway epithelium. The feasibility ofthis approach has been demonstrated in vivo in experimental animals with a replication deficient recombinant adenovirus containing the normal CFTR cDNA (6) .
The adenovirus has a number of features that make it suitable for somatic gene therapy (7) (8) (9) (10) (11) (12) (13) . First, it can be rendered replication deficient, so that it will deliver an exogenous gene to the target cells without subsequent replication ofthe virus. Second, it can be modified to accept exogenous pieces of DNA < 7.5 kb. Third, in regard to potential safety issues, live adenoviruses are used for in vivo human vaccination, and, although adenoviruses are common human pathogens, no human neoplasms have been associated with adenovirus infection. Fourth, adenovirus can be produced in high titers, a critical requirement for in vivo somatic gene therapy. Finally, some types of adenovirus are tropic for the respiratory epithelium.
In regard to successful gene therapy for CF, the tropism for the respiratory epithelium is very important, since it is in the airway epithelium that the consequences of mutations of the CFTR gene are most dramatic, with abnormal mucus, bacterial colonization, and inflammation that eventually lead to airway derangement and respiratory failure (1, 2) . All available evidence suggests these abnormalities are a consequence of expression ofthe mutant CFTR gene in all types ofairway epithelial cells (3) (4) (5) (14) (15) (16) (17) (18) (19) (20) (21) . In the normal lung, the airway epithelium is comprised of four major cell categories: ciliated, secretory, basal, and undifferentiated cells (22) (23) (24) . In this context, for gene therapy for the respiratory manifestations of CF to be successful, it likely will be necessary to deliver the exogenous gene to all types of airway epithelial cells; i.e., for the adenovirus to be a suitable vector for gene therapy for CF, it must be capable of transferring the exogenous gene to all of the major cell types of the airway epithelial sheet.
Based on this background, the present study is directed toward defining the cell target specificity ofa recombinant adenovirus in the airway epithelium in vivo. To answer this question, we have used a replication deficient recombinant adenovirus containing the Escherichia coli lacZ (,3-galactosidase [,8-gal (33) demonstrated no detectable activity. In vivo infection ofcotton rat lungs. The experimental animals used were cotton rats (Sigmoidon hispidus, 6-8 wk) of either sex. To infect the airway epithelium of cotton rats in vivo, the animals were anesthetized by methoxyfluorane inhalation (13). The In initial studies to demonstrate that the lacZ gene could be transferred to the airway epithelium in vivo, Ad.RSV,Bgal was instilled into the trachea and the animals were killed 72 h later. Blood was removed by cardiac puncture, and lungs and trachea were isolated. The lungs were lavaged twice with 2 ml PBS, and the pulmonary vasculature perfused with PBS. The lungs were removed and evaluated by colorimetric and cytochemical analysis. The colorimetric assay offl-gal activity was performed on homogenate lung lysates, using 2-nitrophenyl-13-D-galactopyranoside as a substrate, as described above. The total protein content of the lung lysates was also quantified using a modification of the Lowry method (BCA protein assay; Pierce Chemical Co., Rockford, IL). The effect of increasing doses of Ad.RSVfgal (107-10'°pfu/animal) on the expression of the lacZ gene in cotton rat lungs in vivo was evaluated by colorimetric assay as described above. For the cytochemical analysis, the lungs were removed and fixed by slow injection via the trachea of 2 ml of cold fixing solution (2% formaldehyde and 0.2% glutaraldehyde in PBS) with an instillation pressure of 25 cm H20. The lungs were then immersed in the same fixing solution (60 min, 40), washed with PBS, and stained by intratracheal infusion and immersion in 5 mM K4Fe(CN)6, 5 mM K3Fe3(CN)6 (Sigma Chemical Co., St. Louis, MO) and 2 mM MgCl2 (Mallinckrodt) in PBS containing 0.5 mg/ml of the X-Gal
Co.] at 20 mg/ml, before dilution into the reaction mixture) for 6 h, 370 (34, 35) . Tissues were identified as positive for f-gal activity by the blue stain of the X-Gal reaction.
To evaluate the diversity of airway epithelial cell targets for in vivo adenovirus-mediated gene transfer, the study was designed to analyze direct lacZ transfer and expression before the time the Ad.RSV,Bgalinfected cells could proliferate and differentiate and the daughter cells express the lacZ gene. In this context, all analyses were carried out 24 h after Ad.RSVfgal instillation. The 24-hr time point was chosen based on two lines of evidence: (a) preliminary studies demonstrating f,-gal activity 6-10 h after exposure of an epithelial cell line to Ad.RSVflgal (not shown); and (b) extensive studies in the literature demonstrating that the airway epithelium proliferates very slowly, with < 1% airway cells entering the proliferative cycle within 24 h (23, 36, 37).
The Ad.RSV#gal vector was instilled as described above, and the animals were killed 24 h later. The lungs were handled and stained with X-Gal as described above. To obtain sections of the proximal bronchi and distal bronchioles, both lungs were then sliced longitudinally along the axis of the main bronchi (38) . The in the proximal airways and 3,300 cells in the distal airways. Epithelial cells in the proximal and distal airways were scored as positive for the expression ofthe lacZ product ifthe characteristic ,3-gal blue color was nuclear/perinuclear or nuclear/perinuclear and in the cytoplasm. For the PBS control animals (n = 8), a total of 6,500 proximal and 4,700 distal airway cells were evaluated. For the Ad-alAT controls (n = 5), a total of 2,900 proximal and 2,900 distal airway cells were evaluated. Only cells with visible sectioned nuclei were considered.
In the proximal bronchi, airway epithelial cells were classified in four categories (ciliated cells, secretory cells, basal cells, and undifferentiated cells) based on the following criteria. Ciliated cells had faintly stained oval shaped nuclei, columnar profiles, and cilia and/or terminal plates at the surface. Secretory cells had no cilia, goblet, or columnar shapes and clear, large vacuoles or small darkly stained granules. Basal cells were small angular shaped cells adjacent to the basal membrane with dense round nuclei, strongly stained cytoplasm, and high nuclear to cytoplasmic ratio. Undifferentiated cells were cells that did not meet any of the criteria listed above.
In the distal bronchioles, airway epithelial cells were also classified into four categories (ciliated cells, secretory cells, basal cells, and undifferentiated cells). Ciliated cells were similar to those in the proximal airway, but were cuboidal shaped. Secretory cells were "golf club" shaped with a smooth surface projecting high above the surrounding ciliated cells; these cells were mainly Clara cells. Basal and the undifferentiated cells had a similar appearance to that described above for the proximal airways.
Statistical evaluation. All data are expressed as mean±SEM, and all statistical comparisons were done with the two-tailed Student's t test.
Results
In vivo adenovirus-directed E. coli lacZ gene expression. After intratracheal administration of Ad.RSV#gal to cotton rats, the presence of 1-gal activity in the lungs could be detected by colorimetric assay (Fig. 2) . Evaluation of lung lysates of animals injected with intratracheal PBS (n = 5) or the control virus Ad-a lAT (10'0 total pfu/animal; n = 5), using a 1-gal colorimetric assay was negative, but 1-gal activity was present in lung lysates ofanimals infected with Ad.RSV13gal (1010 total pfu/animal; n = 3). The 1-gal activity was 6.4±2.0 X 10-2 U/mg of cellular protein. Importantly the 1-galactosidase activity in lungs of animals administered increasing doses of Ad.RSV1gal was dose-dependent. Consistent with the colorimetric data, cytochemical analysis of the lungs of animals that received intratracheal PBS (Fig. 3 A) or the control virus Ad-a lAT (not shown) did not show blue staining; i.e., no 1-gal activity was detected. In contrast, lungs of animals instilled with Ad.RSV13gal appeared intensely blue with 1-gal activity localized to the airways (B) .
A variety of different light microscopic histologic methods all demonstrated that after Ad.RSV1gal intratracheal instillation, the bronchial epithelium of animals could be infected with Ad.RSV13gal and expressed intracellular 1-gal activity at all airway segments evaluated (Fig. 4) . In this regard, after instillation of PBS, no 13-gal activity was noted in the airway epithelium (A). In contrast, instillation ofAd.RSV,Bgal resulted in clear expression of1-gal predominantly in the airway epithelium (B). 13-gal activity was absent in the airways of control animals in paraffin sections evaluated with a nuclear fast red counterstain (A and G). The same was true in paraffin sections stained with hematoxylin-eosin (C) and in frozen sections not counterstained (E). Likewise, after intratracheal administration of the control virus Ad-a lAT, no 1-gal activity was observed in the airway epithelium with any of these histologic methods (not shown). In contrast, with all sectioning and counterstaining methods, 1-gal activity was clearly observed in the airway epithelium after Ad.RSV13gal administration (B, D, F, and H). When counterstained with nuclear fast red, examination of the airway epithelium of animals receiving intratracheal PBS or the control virus Ad-a 1 AT demonstrated no blue staining of the airway epithelial cells (Fig. 5, A-F) ; i.e., no endogenous cytoplasmic 13-galactosidase activity was detected in the airway epithelium. As an additional control, thyroid tissues from the same animals stained with the X-Gal stain showed endogenous cytoplasmic 13-galactosidase activity (not shown).
A B Figure 3 . (Figs. 6 and 7) . This was true for the proximal bronchi (Fig. 6, A and B), including ciliated, secretory, undifferentiated (Fig. 6 , C and D) and basal cells (Fig. 6, C and D; Fig. 7, A-D) . It was also observed in the bronchioles (Fig. 6, E and F) , including ciliated cells, secretory (Clara cells), and the less common undifferentiated (Fig. 6 , G and H) and basal cells (Fig. 6, G and H; Fig. 7 , E and F). Particular attention was dedicated to the identification of (-galactosidase positive basal cells because these cells have a high nuclear/cytoplasmic ratio, and thus it can be difficult to distinguish positive nuclear and perinuclear ,B-galactosidase staining from the hematoxylin stained dark blue nuclei. Quantitative evaluation ofthe diversity ofAd.RSVfgal targets. Quantification of the distribution of ,B-gal positive cells was evaluated using two different counterstains (hematoxylin and nuclear fast red). After Ad.RSV,Bgal administration, the adenovirus vector delivered the lacZ gene to all categories of airway epithelial cells with the distribution ofexpression ofthe lacZ product similar to the normal distribution of the various epithelial cell types in control animals (Fig. 8) . This was true both in proximal bronchi (A and C) and in the bronchioles (B and D). In the large airways of uninfected animals, ciliated and secretory cells predominated with smaller numbers of basal cells and relatively few undifferentiated cells (A). The same cell differential was found in animals receiving intratracheal PBS or the control virus Ad-a I AT (not shown). After intratracheal instillation of Ad.RSV#gal, the lacZ product was observed among all of the cell types in the large airway epithelial sheet, and in similar proportion to the normal distribution of epithelial cell types (A and C; P > 0. 1, all comparisons ofthe proportion of lacZ positive cells to the normal distribution of cell types). Importantly, the differential counts ofbasal cells in control animals and f-galactosidase positive basal cells in Ad.RSVfgal injected animals showed identical results with the nuclear fast red and hematoxylin counterstains (P > 0.1).
The same distribution was found in the small airways. In control animals, ciliated and secretory cells predominated (Fig.   8 B) . Basal cells and undifferentiated cells were relatively rare. Similar observations were made in the animals receiving PBS or the control virus Ad-alAT (not shown). Analysis of the distribution of bronchiolar epithelial cells expressing the lacZ gene after Ad.RSV#gal administration showed a pattern similar to the normal cell distribution (B and D; P > 0. 1, all comparisons of the proportion of lacZ positive cells to the normal distribution ofcell types). The same differential counts ofbasal cells in control animals, and of,B-galactosidase positive basal cells in animals injected with Ad.RSV,Bgal, were observed with the nuclear fast red counterstain as with hematoxylin counterstain (P> 0.1).
Discussion
A possible approach to therapy ofrespiratory manifestations of cystic fibrosis is organ-specific delivery of the normal gene to the respiratory epithelium of affected individuals. The feasibility of this approach has been demonstrated in experimental animals using a recombinant replication deficient adenovirus containing the normal human cystic fibrosis transmembrane conductance regulator cDNA (6) . While these studies demonstrated that the recombinant vector could transfer an exogenous gene to the airway epithelium in vivo, the distribution of epithelial cell types expressing the exogenous gene is unknown. The answer is critical because if this approach to gene therapy of CF is to work, it may be necessary for the exogenous gene to be delivered to all airway epithelial cells requiring CFTR for their normal function. Which airway epithelial cells must express CFTR is not known, but all available evidence suggests that all major categories ofairway epithelial cells express CFTR (3) (4) (5) (14) (15) (16) (17) (18) (19) (20) (21) . Thus, at least until evidence is produced to the contrary, the objective for gene therapy for the respiratory manifestations ofCF is to deliver the normal gene to all categories of the airway epithelium, including large to small airways.
The present study answers this question for adenovirus vectors, using the lacZ reporter gene to identify target cells. The data demonstrate that a replication deficient recombinant adenovirus vector can transfer an exogenous gene in a dose-dependent fashion to the epithelium of all segments of the intrapulmonary airways. Importantly, the composition ofthe epithelial cell population expressing the transferred gene is similar to the cell distribution in the normal epithelium; i.e., intratracheal administration of an adenovirus vector is capable of transferring an exogenous marker gene to all categories of airway epithelial cells. In the context that intratracheal administration of a recombinant adenovirus vector containing the normal human CFTR cDNA results in expression ofthe transferred gene in the lungs of experimental animals (6), these observations suggest the adenovirus may be a useful vector for gene therapy for the respiratory manifestations of cystic fibrosis. In this re- One caveat regarding this conclusion comes from the knowledge that the airway epithelium of the cotton rats (S. hispidus, a rodent that has similarities to rat and hamster) is not identical to that of the human. The cotton rats were used in these studies because of the extensive data suggesting the cotton rat is similar to the human in regard to sensitivity to adenovirus airway infection (39) . However, like other rodents and most other experimental animals, the cotton rat large airway epithelium differs from the human in that the cotton rat has significantly higher proportions of surface secretory cells and lower proportions of submucosal glands (40, 41 for bronchioles. Quantification was done using hematoxylin counterstained sections, see Methods for details as to criteria for each cell category, /3-galactosidase positivity, and total number of animals and cells evaluated. lung for gene transfer using any type of vector. However, since there are no animals that are similar to the human in both the types of respiratory epithelial cells and the sensitiyity to human adenoviruses, and no animal model mimicking all the respiratory manifestations of CF, the final answer to these questions will have to wait for human studies.
Adenoviruses have an advantage as vectors for gene therapy because they are common human pathogens, tropic for the respiratory epithelium. However, a majority of adults have detectable serum antibodies against the sero-group C adenoviruses (including Ad5) (8) . Whether this will pose a problem for gene therapy for CF is difficult to evaluate in vitro or in vivo in animals, because there are no in vitro or in vivo models of the human CF lung.
We 
